BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
(E)-3-(1-((2R, 4S, 5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-2, 4-dioxo-1, 2, 3, 4-tetrahydropyrimidin-5-yl)-N-(6-(2, 2, 2-trifluoroacetamido)hexyl)acrylamide is a TFA-modified nucleoside containing tetracycline and acrylamide groups in its structure.
Molecular Weight
794.81
Molecular Formula
C41H45F3N4O9
Form
White to off-white solid
Purity
≥98%
Applications
(E)-3-(1-((2R, 4S, 5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxytetrahydrofuran-2-yl)-2, 4-dioxo-1, 2, 3, 4-tetrahydropyrimidin-5-yl)-N-(6-(2, 2, 2-trifluoroacetamido)hexyl)acrylamide has potential antitumor activity and inhibits tumor growth by interfering with the proliferation and metastasis of tumor cells.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.